ABSTRACT
Since the advent of breast screening with mammography, the field of breast imaging has continued to develop, refining existing methods and creating new technologies. While some methods are evolving, core goals remain early and accurate diagnosis of breast lesions and responsible radiological and multidisciplinary clinical management of what is found. The original mammography was film-screen mammography, first developed in the 1940s and moulded into recognisable mammographic units in the 1960s. Large, prospective, randomised, controlled breast cancer screening trials started in the 1970s. DBT can also reduce recalls in that true findings, for example, of real architectural distortion and masses, can be more confidently confirmed on initial DBT screening, and can then be evaluated with ultrasound instead of first requiring additional diagnostic mammographic imaging. Non-palpable breast lesions are routinely localised for surgery, using various percutaneous pre-operative localisation methods. MRI compatibility and MRI-guided localisation continue to be challenges for these emerging technologies.
